title: Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
abstract: Using currently available equipment for panoramic hysteroscopy, the size of images viewed cannot be accurately judged because of the magnifying and distorting effects of the objective lens. This study has demonstrated that magnification by the hysteroscope lens can alter the apparent size of images by up to 27%. An additional effect of lens distortion can alter the apparent size of images viewed by up to 28%, depending on the position of the image in the field of view. These effects are independent and may be additive. Thus, the apparent size of intrauterine structures at hysteroscopy may bear little resemblance to their actual size. Image-correction methods are described which reduce the effects of image magnification on the apparent size of an object viewed through the hysteroscope to 7%, and the effect of distortion to 3 %. This technique can greatly improve the accuracy of measurement at hysteroscopy, and has been utilized in this study for the precise measurement of superficial endometrial vascular diameter (mean+/-SEM) in 34 Norplant users (120+/-11.6 microm) and 20 women with spontaneous menorrhagia (74+/-7.2 microm). It has also confirmed the presence of scattered dilated vessels (up to 777 microm in diameter) on the endometrial surface in some Norplant users.
authors.affiliation: Sydney Centre for Reproductive Health Research, Department of Obstetrics and Gynaecology, University of Sydney, NSW, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Hickey
authors.forename: D
authors.initials: D
authors.lastname: Dwarte
authors.forename: I S
authors.initials: IS
authors.lastname: Fraser
mesh_terms: D000293:Adolescent; D000328:Adult; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D004343:Drug Implants; D004438:Ecchymosis / Q000175:diagnosis / Q000473:pathology; D016889:Endometrial Neoplasms / Q000175:diagnosis; D004717:Endometrium / Q000098:blood supply; D005260:Female; D006801:Humans; D015907:Hysteroscopy / Q000379:methods*; D016912:Levonorgestrel / Q000009:adverse effects*; D008595:Menorrhagia / Q000473:pathology*; D011127:Polyps / Q000175:diagnosis; D011693:Purpura / Q000175:diagnosis / Q000473:pathology; D012680:Sensitivity and Specificity; D014599:Uterus / Q000098:blood supply*
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel